Avadel Pharmaceuticals (AVDL) Interest Expenses: 2014-2020
Historic Interest Expenses for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Dec 2020 value amounting to $3.3 million.
- Avadel Pharmaceuticals' Interest Expenses rose 3.70% to $3.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was $12.9 million, marking a year-over-year increase of 3.72%. This contributed to the annual value of $10.8 million for FY2024, which is N/A change from last year.
- Avadel Pharmaceuticals' Interest Expenses amounted to $3.3 million in Q4 2020, which was up 1.50% from $3.3 million recorded in Q3 2020.
- Avadel Pharmaceuticals' 5-year Interest Expenses high stood at $3.3 million for Q4 2020, and its period low was $175,000 during Q1 2016.
- Moreover, its 3-year median value for Interest Expenses was $3.1 million (2019), whereas its average is $3.0 million.
- Its Interest Expenses has fluctuated over the past 5 years, first dropped by 0.38% in 2017, then soared by 1,057.79% in 2018.
- Over the past 5 years, Avadel Pharmaceuticals' Interest Expenses (Quarterly) stood at $261,000 in 2016, then grew by 0.77% to $263,000 in 2017, then spiked by 1,057.79% to $3.0 million in 2018, then increased by 4.76% to $3.2 million in 2019, then increased by 3.70% to $3.3 million in 2020.
- Its Interest Expenses stands at $3.3 million for Q4 2020, versus $3.3 million for Q3 2020 and $3.2 million for Q2 2020.